Key facts
- This page summarizes Daniel E. Ryweck's Form 4 filing for Silo Pharma, Inc. (SILO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2023, 16:17.
Daniel E. Ryweck - 26 May 2023 Form 4 Insider Report for Silo Pharma, Inc. (SILO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- SILO
- Reported as of
- 26 May 2023
- Net transaction value
- +$2,126
- SEC form
- 4
- Accepted by SEC
- 26 May 2023, 16:17:23 UTC
- Prior SEC filing
- 04 Oct 2022
- Next SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel E. Ryweck
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Ryweck filed Form 4 for Silo Pharma, Inc. (SILO) on 26 May 2023.
Change
- Previous filing in this sequence was filed on 04 Oct 2022.
- Current net transaction value: +$2,126.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SILO
transaction
Common Stock
Purchase
- Transaction value
- $2,126
- Shares
- +1,000
- Change %
- +25%
- Price
- $2.13
- Shares after
- 5,000
- Date
- 26 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.